A potential cause for the conflicting evidence is that NF-κB activation in oligodendrocytes has also been traced to pancreatic endoplasmic reticulum kinase (PERK) signaling, an IKK-independent pathway in models of EAE and MS [19,57,58]. The gene discussed is NFKB1; the disease is myeloid sarcoma.